| Product Name | MF | CAS | Details |
|---|
| H-FRDYVDRFYKTLRAE-OH | Details |
| Ethyl 4-aminoquinoline-2-carboxylate | C12H12N2O2 | 142425-92-1 | Details |
| 6-Bromo-1-methyl-1H-benzo[D][1,3]oxazine-2,4-dione | C9H6BrNO3 | 22721-17-1 | Details |
| 4-Chloro-2-((dimethylamino)methyl)aniline | C9H13ClN2 | 1022251-72-4 | Details |
| Disalicylimide | C14H11NO4 | 1972-71-0 | Details |
| 6-Methoxykaempferol 3-o-glucoside | C22H22O12 | 63422-27-5 | Details |
| Endo-BCN-PEG2-alcohol | C17H27NO5 | 1807501-85-4 | Details |
| 2-Methyl-4-nitrophenol | C7H7NO3 | 99-53-6 | Details |
| 3-(3,5-Difluoro-4-hydroxyphenyl)prop-2-enoic acid | C9H6F2O3 | 1262019-00-0 | Details |
| C1ORF151 Blocking Peptide | Details |
| 2-Hydroxy-1-(1,2,3,4-tetrahydroisoquinolin-2-yl)ethan-1-one | C11H13NO2 | 73251-21-5 | Details |
| 2-Hydrazinyl-7-methoxy-4-methylquinoline | C11H13N3O | 97892-65-4 | Details |
| 2-Oxaspiro[3.5]nonan-7-ol | C8H14O2 | 2092707-38-3 | Details |
| Methyl 3-aminocyclohexane-1-carboxylate | C8H15NO2 | 87091-29-0 | Details |
| NVL antibody | Details |
| Forsythoside B | C34H44O19 | 81525-13-5 | Details |
| 4-Phenyl-1H-1,2,3-triazole-5-carbonitrile | C9H6N4 | 14677-11-3 | Details |
| RLBP1 protein (His tag) | Details |
| 1-(2-Methoxy-5-methylphenyl)-3-(4H-1,2,4-triazol-4-yl)urea | C11H13N5O2 | 708236-68-4 | Details |
| (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-nitrophenyl carbonate | C12H9NO8 | 173604-87-0 | Details |
| 3-Cyclopropylpiperidine hydrochloride | C8H16ClN | 942511-56-0 | Details |
| Elafibranor | C22H24O4S | 824932-88-9 | Details |
| 3-Methoxy-4-[(2-nitrobenzyl)oxy]benzaldehyde | C15H13NO5 | 331463-81-1 | Details |
| Peptidase D Blocking Peptide | Details |
| Nodularin | C41H60N8O10 | 118399-22-7 | Details |
| Hsp70 antibody (N-terminus) | Details |
| 2-[3-(Difluoromethyl)-1-methyl-1H-pyrazol-4-yl]acetonitrile | C7H7F2N3 | 2228637-01-0 | Details |
| 4-[(3-Propyl-1,2,4-oxadiazol-5-yl)methyl]piperidine hydrochloride | C11H20ClN3O | 1909305-95-8 | Details |
| 2-(4-Chloro-3-methoxyphenyl)acetic acid | C9H9ClO3 | 13726-19-7 | Details |
| TBX22 antibody | Details |
| 3-{5H,6H,7H,8H-Imidazo[1,5-a]pyridin-3-yl}piperidine | C12H19N3 | 1540988-34-8 | Details |
| 2-{[(tert-butoxy)carbonyl]amino}-2-(3-methoxyphenyl)acetic acid | C14H19NO5 | 40512-37-6 | Details |
| N-(7-Oxa-9,9,9-trifluorononyl)deoxynojirimycin | C14H26F3NO5 | 383417-50-3 | Details |
| FAM160B1 Blocking Peptide | Details |
| 5'-O-DMT-5-iodo-2'-O-methyluridine | C31H31IN2O8 | 588691-24-1 | Details |
| 2-(2,2,3,3-Tetrafluoropropoxy)ethan-1-amine hydrochloride | C5H10ClF4NO | 1803607-46-6 | Details |
| 3-Amino-1-[3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one, acetic acid | C18H19F6N5O3 | 2137530-88-0 | Details |
| 5-(4-Amino-1H-pyrazol-1-yl)piperidin-2-one | C8H12N4O | 1824344-63-9 | Details |
| 3-Chloro-11-methyl-5-(morpholin-4-ylmethyl)-8-thia-4,6-diazatricyclo[7.4.0.0,2,7]trideca-1(9),2,4,6-tetraene | C16H20ClN3OS | 735342-62-8 | Details |
| 6-Methyl-5-(1-methyl-1H-pyrazol-4-yl)pyridin-2-amine | C10H12N4 | 1429777-48-9 | Details |
| (+/-)-7-Hydroxy-1,2,3,4-tetrahydro-3-isoquinoline-4-carboxylic acid methyl ester hydrochloride | C11H14ClNO3 | 672310-19-9 | Details |
| 1-(3-Chloropyridin-2-yl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid | C10H5ClF3N3O2 | 1265323-81-6 | Details |
| Thiamine-(4-methyl-13C-thiazol-5-yl-13C3) hydrochloride | C12H18Cl2N4OS | 1257525-77-1 | Details |
| ER81 antibody | Details |
| CSRP2 antibody | Details |
| Thyroglobulin Light Tryptic Peptide Standard (4nmol) | Details |
| N-Boc 1-o-t-butyl 5-o-methoxy L-glutamic acid | C15H27NO6 | 24277-38-1 | Details |
| 2,3-Dihydro-1H-isoindole-4-carboxylic acid hydrochloride | C9H10ClNO2 | 1965309-40-3 | Details |
| 1-[2-(Naphthalen-2-yl)acetyl]pyrrolidine-2-carboxylic acid | C17H17NO3 | 130654-11-4 | Details |
| 2,3,6-Trimethoxybenzoic Acid | C10H12O5 | 60241-74-9 | Details |
| 1-Hydroxy-2-acetonaphthone | C12H10O2 | 711-79-5 | Details |
| CD5 antibody (biotin) | Details |
| 4-Bromo-3-methylbenzene-1-carbothioamide | C8H8BrNS | 41963-21-7 | Details |
| 6-Chloro-4-methylpyridine-3-sulfonyl chloride | C6H5Cl2NO2S | 889944-76-7 | Details |
| cis-4-Hexen-1-ol | C6H12O | 928-91-6 | Details |
| (4-(6-Aminopyridazin-3-yl)piperidin-1-yl)(4-(4-(trifluoromethyl)phenoxy)phenyl)methanone | C23H21F3N4O2 | 2361241-23-6 | Details |
| TSC22D3 protein (His tag) | Details |
| 1,5-Naphthyridine-3-carbaldehyde | C9H6N2O | 959617-49-3 | Details |
| 1-[(5-Bromothiophen-2-yl)sulfonyl]piperidine-2-carboxylic acid | C10H12BrNO4S2 | 1008571-93-4 | Details |
| Ac-EQKLISEEDLC-OH | Details |
| Perfluorophenyl 3-(2-(2-(3-(2,5-dioxo-2H-pyrrol-1(5H)-yl)propanamido)ethoxy)ethoxy)propanoate | C20H19F5N2O7 | 1347750-81-5 | Details |
| 3-Benzyl-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-7-carboxylic acid | C16H12N2O4 | 687580-04-7 | Details |
| 4-Chloro-2-methylnaphthalen-1-amine | C11H10ClN | 341028-97-5 | Details |
| 3-Cyclohexyl-N-hydroxypropanamide | C9H17NO2 | 651738-74-8 | Details |
| N-{3-[4-(2-Chloroacetyl)phenyl]propyl}acetamide | C13H16ClNO2 | 852851-66-2 | Details |
| Abl Cytosolic Substrate | C64H101N15O16 | 168202-46-8 | Details |
| IL1F9 antibody | Details |
| ATXN2 antibody | Details |
| HIV-1 Nef 137-145 (HLA-A*02:01) | Details |
| 4,8-Dichloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one | C14H9Cl2NO | 133330-60-6 | Details |
| 4-Amino-N-butylpyridine-2-sulfonamide | C9H15N3O2S | 1803600-69-2 | Details |
| 4-(Mercaptomethyl)benzoic acid | C8H8O2S | 39088-65-8 | Details |
| Methyl 7-fluoro-1,2,3,4-tetrahydroisoquinoline-5-carboxylate hydrochloride | C11H12FNO2.ClH | 2305252-86-0 | Details |
| Gangaleoidin | C18H14Cl2O7 | 55365-63-4 | Details |
| TMCC3 antibody | Details |
| 2-Chloro-1-(4-methyl-2-thienyl)-ethanone | C7H7ClOS | 556110-51-1 | Details |
| (6-Methylpyrazin-2-yl)methanamine dihydrochloride | 2137602-55-0 | Details |
| Fmoc-N-Me-D-Asp(OtBu)-OH | C24H27NO6 | 1799443-40-5 | Details |
| 2-{[3-(Trifluoromethyl)phenyl]methyl}pyrrolidine | C12H14F3N | 933687-77-5 | Details |
| 2-Methyl-6-(pyrrolidine-1-carbonyl)aniline | C12H16N2O | 926267-84-7 | Details |
| 2-(4-Nitrophenyl)furan | C10H7NO3 | 28123-72-0 | Details |
| CREG1 antibody | Details |
| 3,5-Dimethyl-1-(prop-2-yn-1-yl)-1H-pyrazole | C8H10N2 | 27258-02-2 | Details |
| 2-(3-Bromophenyl)hexan-2-amine | C12H18BrN | 1249546-05-1 | Details |
| Ac-CGVNNSNEDFREENLKTAN-NH2 | Details |
| 2,2-Dimethyl-3-(propan-2-yloxy)cyclobutan-1-one | C9H16O2 | 1539417-15-6 | Details |
| 3,5-Dichloro-2-hydroxybenzenesulfonic acid, disodium salt | C6H5Cl2NaO4S | 95041-38-6 | Details |
| Sodium bitartrate monohydrate | C4H7NaO7 | 6131-98-2 | Details |
| ANP (7-20) | Details |
| ISG15 Blocking Peptide | Details |
| Ethyl 2-amino-2-(1H-indol-3-yl)acetate | C12H14N2O2 | 91566-74-4 | Details |
| UNC 4203 | C30H44N6O | 1818234-19-3 | Details |
| Ethyl 2-(Trifluoromethyl)-1,3-Thiazole-4-Carboxylate | C7H6F3NO2S | 133046-46-5 | Details |
| H-FQSVFTVTR^-OH | Details |
| 5-bromo-2,3-dihydro-1H-inden-1-amine hydrochloride | C9H11BrClN | 1197595-75-7 | Details |
| PP2A alpha (methyl L309) Ab | Details |
| 2-(2-Hydroxybenzylidene)hydrazinecarboxamide | C8H9N3O2 | 3030-97-5 | Details |
| Man-3-F N-Glycan | C40H68N2O30 | 110387-51-4 | Details |
| 2-[4-(Trifluoromethyl)pyridin-2-yl]ethan-1-amine | C8H9F3N2 | 1060805-59-5 | Details |
| N-Methyl-4-sulfamoylbenzamide | C8H10N2O3S | 10518-85-1 | Details |
| Product Total： Product Page： | ||||
| 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 | ||||